Literature DB >> 1731109

cis and trans requirements for the selective packaging of adenovirus type 5 DNA.

M Gräble1, P Hearing.   

Abstract

Polar packaging of adenovirus DNA into virions is dependent on the presence of cis-acting sequences at the left end of the viral genome. Our previous analyses demonstrated that the adenovirus type 5 (Ad5) packaging domain (nucleotides 194 to 358) is composed of at least five elements that are functionally redundant. A repeated sequence, termed the A repeat, was associated with packaging function. Here we report a more detailed analysis of the requirements for the selective packaging of Ad5 DNA. By introducing site-directed point mutations into specific A repeat sequences, we demonstrate that the A repeats represent cis-acting functional components of the packaging signal. Additional elements, located outside the originally defined packaging domain boundaries and that resemble the A repeat consensus sequence, also are capable of promoting the packaging of viral DNA. The cis-acting components of the packaging signal appear to be subject to certain spatial constraints for function, possibly reflecting a necessity for the coordinate binding of packaging proteins to these sites. In agreement with this idea, we present evidence that the interaction of a limiting trans-acting factor(s) with the packaging domain in vivo is required for efficient encapsidation of the Ad5 genome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731109      PMCID: PMC240771     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

4.  Characterization of a temperature-sensitive fiber mutant of type 5 adenovirus and effect of the mutation on virion assembly.

Authors:  C C Chee-Sheung; H S Ginsberg
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

Review 5.  DNA packaging by the double-stranded DNA bacteriophages.

Authors:  W C Earnshaw; S R Casjens
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

6.  Temperature-sensitive mutant of adenovirus type 2 blocked in virion assembly: accumulation of light intermediate particles.

Authors:  J C D'Halluin; M Milleville; P A Boulanger; G R Martin
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

7.  Effects of novobiocin on adenovirus DNA synthesis and encapsidation.

Authors:  J C D'Halluin; M Milleville; P Boulanger
Journal:  Nucleic Acids Res       Date:  1980-04-11       Impact factor: 16.971

8.  Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant.

Authors:  M Gräble; P Hearing
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

9.  Polar encapsidation of adenovirus DNA: cloning and DNA sequence of the left end of adenovirus type 3.

Authors:  L D Kosturko; S V Sharnick; C Tibbetts
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

10.  Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis.

Authors:  N D Stow
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  34 in total

1.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

3.  Minimal cis-acting elements required for adenovirus genome packaging.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Construction of an adenovirus type 7a E1A- vector.

Authors:  K Abrahamsen; H L Kong; A Mastrangeli; D Brough; A Lizonova; R G Crystal; E Falck-Pedersen
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivo and in vitro.

Authors:  Pilar Perez-Romero; Ryan E Tyler; Johanna R Abend; Monica Dus; Michael J Imperiale
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 6.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

7.  Dependence of the encapsidation function of the adenovirus L1 52/55-kilodalton protein on its ability to bind the packaging sequence.

Authors:  Pilar Perez-Romero; Kurt E Gustin; Michael J Imperiale
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein.

Authors:  Ryan E Tyler; Sean G Ewing; Michael J Imperiale
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 9.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

10.  The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription.

Authors:  Humayra Ali; Gary LeRoy; Gemma Bridge; S J Flint
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.